Stock market week-in-review for 5 large GI companies — Dec. 11-15

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Dec. 11 to Dec. 15, 2017.

Advertisement

Note: This data was compiled using Yahoo Finance.

1. Allergan Pharmaceuticals

Opened: $168.75 on Dec. 11
Peaked: $175.20 on Dec. 14
Closed: $171.68 on Dec. 15
Percent change between Dec. 11 and Dec. 15: 1.73 percent

2. Exact Sciences Corp.

Opened: $53.58 on Dec. 11
Peaked: $53.96 on Dec. 11
Closed: $51.56 on Dec. 15
Percent change between Dec. 11 and Dec. 15: -3.77 percent

3. Johnson & Johnson

Opened: $140.90 on Dec. 11
Peaked: $143.57 on Dec. 12
Closed: $142.46 on Dec. 15
Percent change between Dec. 11 and Dec. 15: 1.1 percent

4. Synergy Pharmaceuticals

Opened: $1.93 on Dec. 11
Peaked: $2.10 on Dec. 15
Closed: $2.01 on Dec. 15
Percent change between Dec. 11 and Dec. 15: 4.14 percent

5. Valeant Pharmaceuticals

Opened: $19.80 on Dec. 11
Peaked: $22.81 on Dec. 13
Closed: $19.71 on Dec. 15
Percent change between Dec. 11 and Dec. 15: -0.45 percent

More articles on gastroenterology: 
GI leader to know: Dr. Anil Sharma of Gastroenterology Group of Rochester
82% of early-onset CRC cases misdiagnosed — 10 study insights
Takeda, TiGenix’s complex perianal fistulas treatment receives 1st ever positive EMA opinion — 3 insights

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.